Our data suggested that inhibition of MET and AXL phosphorylation activities through LY2801653 in turn led to marked suppression of downstream oncogenic signaling pathways, which might play important roles in proliferation and angiogenesis‐related behaviors of cancer. The gene discussed is MET; the disease is cancer.